[1]
Y. Sun, “Equity Financing Potential for Leading R&D of Small and Medium-Sized Biomedical Corporations”, Econ. Sci., vol. 10, no. 2, pp. 60–78, Feb. 2024, doi: 10.22394/2410-132X-2024-10-2-60-78.